Cryptotanshinone from the Salvia miltiorrhiza Bunge Attenuates Ethanol-Induced Liver Injury by Activation of AMPK/SIRT1 and Nrf2 Signaling Pathways
- Document Type
- Publications · Journal Article
- Registered DB
- SCIEScopus
- Journal Ranking
- JCR Q1Scopus Q1
- Journal
- INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES21(1) · 2020
- Citation
- Web of Science 121Scopus 137
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 4.556
- ISSN
- 1661-6596
Authors
- Nagappan, ArulkumarFirst authorHealthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan, 50612, Korea
- Kim, Ji HyunHealthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan, 50612, Korea
- Jeong, Dae yeongHealthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan, 50612, Korea
- Jung, Myeong-hoCorresponding authorHealthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan, 50612, Korea
Abstract
Cryptotanshinone (CT), a diterpene that is isolated from Salvia miltiorrhiza Bunge, exhibits anti-cancer, anti-oxidative, anti-fibrosis, and anti-inflammatory properties. Here, we examined whether CT administration possess a hepatoprotective effect on chronic ethanol-induced liver injury. We established a chronic alcohol feeding mouse model while using C57BL/6 mice, and examined the liver sections with hematoxylin-eosin (H&E) and Oil Red O (ORO) staining. Further, we analyzed the lipogenesis, fatty acid oxidation, oxidative stress, and inflammation genes by using quantitative polymerase chain reaction (qPCR) and immunoblotting in in vivo, and in vitro while using HepG2 and AML-12 cells. CT treatment significantly ameliorated ethanol-promoted hepatic steatosis, which was consistent with the decreased hepatic triglyceride levels. Interestingly, CT activated the phosphorylation of AMP-activated protein kinase (AMPK), sirtuin 1 (SIRT1), and nuclear factor E2-related factor 2 (Nrf2) proteins. Importantly, compound C (AMPK inhibitor) significantly blocked the CT-mediated reduction in TG accumulation, but not Ex52735 (SIRT1 inhibitor), which suggested that CT countering ethanol-promoted hepatic steatosis is mediated by AMPK activation. Furthermore, CT significantly inhibited cytochrome P450 2E1 (CYP2E1) and enhanced both the expression of antioxidant genes and hepatic glutathione levels. Finally, CT inhibited the ethanol-induced inflammation in ethanol-fed mice and HepG2 cells. Overall, CT exhibits a hepatoprotective effect against ethanol-induced liver injury by the inhibition of lipogenesis, oxidative stress, and inflammation through the activation of AMPK/SIRT1 and Nrf2 and the inhibition of CYP2E1. Therefore, CT could be an effective therapeutic agent for treating ethanol-induced liver injury.
Keywords
cryptotanshinoneAMP-activated protein kinasenuclear factor E2-related factor 2alcohol liver diseasecytochrome P450 2E1sirtuin 1CULTURED RAT HEPATOCYTESPROTEIN-KINASE CASCADEINDUCED FATTY LIVEROXIDATIVE STRESSGENE-EXPRESSIONDISEASE PATHOGENESISDOWN-REGULATIONTANSHINONE-IIAALCOHOLAMPK
Identifiers
- Scopus EID
- 2-s2.0-85077559923
- WoS UID
- 000515378000265



Login
Back to Publication list